List view / Grid view

Dr Jill O’Donnell-Tormey (Cancer Research Institute)

 

article

Antibodies allow for a targeted approach to cancer therapy

Cancer can be an immovable beast, tenacious in its numerous…

26 March 2020 | By

Cancer can be an immovable beast, tenacious in its numerous mechanisms to thrive and grow. However, the healthcare industry has an ever-expanding arsenal of therapies designed to thwart it, with variable levels of success. Nikki Withers speaks to Dr Jill O’Donnell-Tormey, CEO and Director of Scientific Affairs at the Cancer…

article

Antibodies In-Depth Focus 2020

This In-Depth Focus includes articles on antibodies as a treatment…

24 March 2020 | By

This In-Depth Focus includes articles on antibodies as a treatment for COVID-19, the importance of understanding every aspect of an ADC and the potential of antibodies as a targeted cancer therapeutic.